Marie Luby1, Steven J Warach2, Zurab Nadareishvili2, José G Merino2. 1. From the Section on Stroke Diagnostics and Therapeutics, National Institute of Neurological Disorders and Stroke, Bethesda, MD (M.L., S.J.W., Z.N., J.G.M.); Department of Neurology and Neurotherapeutics, Seton/University of Texas Southwestern, Austin (S.J.W.); and Johns Hopkins Community Physicians, Bethesda, MD (Z.N., J.G.M.). lubym@ninds.nih.gov. 2. From the Section on Stroke Diagnostics and Therapeutics, National Institute of Neurological Disorders and Stroke, Bethesda, MD (M.L., S.J.W., Z.N., J.G.M.); Department of Neurology and Neurotherapeutics, Seton/University of Texas Southwestern, Austin (S.J.W.); and Johns Hopkins Community Physicians, Bethesda, MD (Z.N., J.G.M.).
Abstract
BACKGROUND AND PURPOSE: We hypothesize that reversal in diffusion-weighted imaging (DWI) volume at 24 hours predicts favorable clinical outcome only if accompanied by immediate reperfusion. Our aim was to quantify the immediate DWI and mean transit time changes at 2 and 24 hours after intravenous tissue-type plasminogen activator to evaluate the effect of reperfusion and DWI change on outcome. METHODS: Patients were selected from the Lesion Evolution in Stroke and Ischemia On Neuroimaging Project if they had an acute MRI with evaluable DWI and perfusion-weighted imaging, were treated with standard intravenous tissue-type plasminogen activator, had post-thrombolysis MRI with evaluable DWI and perfusion-weighted imaging at 2 and 24 hours and had follow-up fluid attenuated inversion recovery MRI at discharge through 90 days. A reader measured the DWI, mean transit time, and fluid attenuated inversion recovery volumes using a validated technique. A vascular neurologist scored the National Institutes of Health Stroke Scale at admit, 2, and 24 hours and the modified Rankin Scale at discharge, 5, 30, and 90 days. Favorable clinical outcome was defined as modified Rankin Scale of 0 or 1. RESULTS: Seventy-one patients met the study criteria with mean (±SD) age of 71.6 (±16.4) years, 58% women, median admit National Institutes of Health Stroke Scale 9 (interquartile range, 4-18), median onset to triage 45 minutes (30-65), and median first MRI to intravenous tissue-type plasminogen activator 47 minutes (39-59). In binary multiple logistic regression analysis, younger age (odds ratio, 1.165; P=0.014; 95% confidence interval [CI], 1.031-1.316), lower admit National Institutes of Health Stroke Scale (odds ratio, 1.221; P=0.012; 95% confidence interval, 1.045-1.427), decrease in mean transit time volume at 2 hours (odds ratio, 1.021; P=0.031; 95% confidence interval, 1.002-1.040), and decrease in DWI volume at 24 hours (odds ratio, 1.173; P=0.027; 95% confidence interval, 1.018-1.351) were significant predictors of favorable clinical outcome. CONCLUSIONS: Reversal of the DWI volume at 24 hours because of immediate reperfusion in patients post thrombolysis is predictive of favorable clinical outcome.
BACKGROUND AND PURPOSE: We hypothesize that reversal in diffusion-weighted imaging (DWI) volume at 24 hours predicts favorable clinical outcome only if accompanied by immediate reperfusion. Our aim was to quantify the immediate DWI and mean transit time changes at 2 and 24 hours after intravenous tissue-type plasminogen activator to evaluate the effect of reperfusion and DWI change on outcome. METHODS:Patients were selected from the Lesion Evolution in Stroke and Ischemia On Neuroimaging Project if they had an acute MRI with evaluable DWI and perfusion-weighted imaging, were treated with standard intravenous tissue-type plasminogen activator, had post-thrombolysis MRI with evaluable DWI and perfusion-weighted imaging at 2 and 24 hours and had follow-up fluid attenuated inversion recovery MRI at discharge through 90 days. A reader measured the DWI, mean transit time, and fluid attenuated inversion recovery volumes using a validated technique. A vascular neurologist scored the National Institutes of Health Stroke Scale at admit, 2, and 24 hours and the modified Rankin Scale at discharge, 5, 30, and 90 days. Favorable clinical outcome was defined as modified Rankin Scale of 0 or 1. RESULTS: Seventy-one patients met the study criteria with mean (±SD) age of 71.6 (±16.4) years, 58% women, median admit National Institutes of Health Stroke Scale 9 (interquartile range, 4-18), median onset to triage 45 minutes (30-65), and median first MRI to intravenous tissue-type plasminogen activator 47 minutes (39-59). In binary multiple logistic regression analysis, younger age (odds ratio, 1.165; P=0.014; 95% confidence interval [CI], 1.031-1.316), lower admit National Institutes of Health Stroke Scale (odds ratio, 1.221; P=0.012; 95% confidence interval, 1.045-1.427), decrease in mean transit time volume at 2 hours (odds ratio, 1.021; P=0.031; 95% confidence interval, 1.002-1.040), and decrease in DWI volume at 24 hours (odds ratio, 1.173; P=0.027; 95% confidence interval, 1.018-1.351) were significant predictors of favorable clinical outcome. CONCLUSIONS: Reversal of the DWI volume at 24 hours because of immediate reperfusion in patients post thrombolysis is predictive of favorable clinical outcome.
Authors: Werner Hacke; Greg Albers; Yasir Al-Rawi; Julien Bogousslavsky; Antonio Davalos; Michael Eliasziw; Michael Fischer; Anthony Furlan; Markku Kaste; Kennedy R Lees; Mariola Soehngen; Steven Warach Journal: Stroke Date: 2004-11-29 Impact factor: 7.914
Authors: A E Baird; K O Lövblad; J F Dashe; A Connor; C Burzynski; G Schlaug; I Straroselskaya; R R Edelman; S Warach Journal: Cerebrovasc Dis Date: 2000 Nov-Dec Impact factor: 2.762
Authors: José G Merino; Lawrence L Latour; Jason W Todd; Marie Luby; Peter D Schellinger; Dong-Wha Kang; Steven Warach Journal: Stroke Date: 2007-09-27 Impact factor: 7.914
Authors: Clinton D Morgan; Marcus Stephens; Scott L Zuckerman; Magarya S Waitara; Peter J Morone; Michael C Dewan; J Mocco Journal: Interv Neuroradiol Date: 2015-06-10 Impact factor: 1.610
Authors: Shreyansh Shah; Marie Luby; Karen Poole; Teresa Morella; Elizabeth Keller; Richard T Benson; John K Lynch; Zurab Nadareishvili; Amie W Hsia Journal: Neurology Date: 2015-05-13 Impact factor: 9.910
Authors: Marie Luby; José G Merino; Rachel Davis; Saeed Ansari; Marc Fisher; Amie W Hsia; Yongwoo Kim; Lawrence L Latour; Evan S McCreedy; Rena Sukhdeo Singh; Clinton B Wright; John K Lynch Journal: Cerebrovasc Dis Date: 2021-12-13 Impact factor: 3.104
Authors: Eckhard Schlemm; Thies Ingwersen; Alina Königsberg; Florent Boutitie; Martin Ebinger; Matthias Endres; Jochen B Fiebach; Jens Fiehler; Ivana Galinovic; Robin Lemmens; Keith W Muir; Norbert Nighoghossian; Salvador Pedraza; Josep Puig; Claus Z Simonsen; Vincent Thijs; Anke Wouters; Christian Gerloff; Götz Thomalla; Bastian Cheng Journal: Nat Commun Date: 2021-05-10 Impact factor: 14.919
Authors: Anne L Abbott; Mauro Silvestrini; Raffi Topakian; Jonathan Golledge; Alejandro M Brunser; Gert J de Borst; Robert E Harbaugh; Fergus N Doubal; Tatjana Rundek; Ankur Thapar; Alun H Davies; Anthony Kam; Joanna M Wardlaw Journal: Front Neurol Date: 2017-10-18 Impact factor: 4.003
Authors: Rachel L Hawe; Sonja E Findlater; Jeffrey M Kenzie; Michael D Hill; Stephen H Scott; Sean P Dukelow Journal: J Am Heart Assoc Date: 2018-09-18 Impact factor: 5.501